Literature DB >> 7392066

Immediate causes of death in Burkitt lymphoma patients in Ibadan.

J I Durodola.   

Abstract

A retrospective study was conducted of 41 patients with Burkitt lymphoma who had partial or complete records of both clinical and pathologic features of their disease, that is, clinical observations immediately before death and pathological findings at sub-sequent post-mortem examinations.The immediate causes of death in five patients were cardiac failure and related conditions; in seven patients, hepatic, renal, or adrenal failure; in ten patients, hemorrhage from necrotic tumor; and in 12 patients, miscellaneous causes of death were recorded. In seven patients, no definite cause of death could be found.Results of these patients and a survey of reported cases lead to the conclusion that effective supportive treatment might be a life-saving adjuvant regimen in treatment of Burkitt lymphoma patients, and should be instituted as soon as the diagnosis of the disease is made.

Entities:  

Mesh:

Year:  1980        PMID: 7392066      PMCID: PMC2552554     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  4 in total

1.  Burkitt's lymphoma in Ibadan: response to various chemotherapeutic agents and long-term survivors.

Authors:  J I Durodola
Journal:  J Natl Med Assoc       Date:  1976-07       Impact factor: 1.798

2.  Burkitt's lymphoma in Ibadan: response to various doses of cyclophosphamide and long-term survivors.

Authors:  J I Durodola
Journal:  Eur J Cancer       Date:  1976-06       Impact factor: 9.162

3.  Causes of death in patients with burkitt's lymphoma--the role of supportive care in overall management.

Authors:  I T Magrath; C Semawere; J Nkwocha
Journal:  East Afr Med J       Date:  1974-09

4.  Administration of cyclophosphamide during late pregnancy and early lactation: a case report.

Authors:  J I Durodola
Journal:  J Natl Med Assoc       Date:  1979-02       Impact factor: 1.798

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.